Globus Medical (GMED) Payables (2011 - 2026)

Globus Medical (GMED) has reported Payables for 16 consecutive years, with $106.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Payables rose 22.78% year-over-year to $106.9 million; the trailing twelve-month figure through Jun 2026 stood at $106.9 million (up 22.78% YoY), and the FY2025 full-year result was $98.9 million, up 31.6% from the prior year.
• Payables advanced to $106.9 million in Q2 2026 per GMED's latest filing, from $103.7 million in the prior quarter.
• Across five years, Payables topped out at $106.9 million in Q2 2026 and bottomed at $26.1 million in Q1 2022.
• Historically, Payables has averaged $64.0 million across 5 years, with a median of $62.4 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Payables jumped 171.92% in 2023, then slumped 33.82% in 2024.
• Over 5 years, Payables stood at $36.1 million in 2022, then surged by 56.98% to $56.7 million in 2023, then soared by 32.55% to $75.1 million in 2024, then surged by 31.6% to $98.9 million in 2025, then rose by 8.18% to $106.9 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $106.9 million, $103.7 million, and $98.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.